iPLATO Healthcare
The myGP platform, developed by iPLATO, is the only GP IT Futures Supplier to provide a population-wide digital-first solution. Interoperable with all major clinical systems it provides patient messaging, preGP intelligent care navigation and remote consultation with video. The most downloaded medical app in the country myGP allows patients to access services directly at their GP service. Proven to reduce costs for practices and CCGs, help to retain workforce and patients as well as save the NHS money.
Why myGP?
Our service was recommended for use nationally in The Independent Review of Cancer Screening Services by Sir Mike Richards. It has proven to increase the uptake of national screening programmes, health checks, vaccinations and been used as a mass-communication method during the COVID-19 outbreak.
It has never been more important for patients to obtain easy access to the appropriate support and/or information about healthcare services. With fewer opportunities for face-to-face contact, text messaging has become a key method of patient communication.
The most reliable source of patient data is in the patients medical record. Our myGP Engagement Hub is able to extract data from patient records across a CCG, STP or entire region to centralise patient communication. The platform can target specific criteria of patients via multiple communication methods at scale, without the need for practices to be involved.
We have years of experience in delivering large scale patient engagement programmes, reaching millions of patients each week. Some of these include:
- Regional Covid-19 communications
- Invitations to vaccinations and Covid-19 testing for eligible groups
- Signposting to specialist services, e.g. talking therapies, smoking cessation and diabetes management
- Invitations for cancer screening services, e.g. text reminders and agent calls
- Notices about access and changes to the provision of services
Our London-wide text reminder programme increased uptake of cervical screening by an additional 6.3%. More recently, over 79% of patients responded to an SMS invitation to attend rapid testing for Covid-19.
The product is simple. Once practice consent is obtained, we send a text message with a clear call-to-action to a targeted group of patients on their behalf.
